NANOTHERAPEUTICS
Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company's technologies can be used with all drug types ranging from small molecules to proteins and peptides. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.
NANOTHERAPEUTICS
Industry:
Biopharma Biotechnology Manufacturing
Founded:
1999-01-01
Address:
Alachua, Florida, United States
Country:
United States
Website Url:
http://www.nanotherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(386)462-9663
Email Addresses:
[email protected]
Total Funding:
66.5 M USD
Technology used in webpage:
Domain Not Resolving Euro IPv6 Google Maps Google Maps API Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS ReCAPTCHA V2 WooCommerce
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
White Oak Global Advisors
White Oak Global Advisors investment in Debt Financing - Nanotherapeutics
Trinity Capital
Trinity Capital investment in Debt Financing - Nanotherapeutics
Hercules Capital
Hercules Capital investment in Debt Financing - Nanotherapeutics
Official Site Inspections
http://www.nanotherapeutics.com
Unable to get host informations!!!
More informations about "Nanotherapeutics"
About - Nanoscope Therapeutics
Currently, Ms. Bhattacharya sits on the Board of Directors of the Biotechnology Innovation Organization (BIO) where she serves on the Health Section Governing Board, and the …See details»
Nanoscope Therapeutics
Nanoscope Therapeutics treibt die Gentherapie mit umgebungslichtempfindlichen Molekülen voran und gibt Millionen von Menschen Hoffnung auf ein neues Sehvermögen, die durch degenerative Netzhauterkrankungen erblindet sind, …See details»
Nanotherapeutics - Crunchbase Company Profile
Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities,See details»
Nanoscope Therapeutics Inc. | LinkedIn
We are pleased to announce that Nanoscope Therapeutics Inc. will be presenting at the H.C. Wainwright & Co., LLC 3rd Annual BioConnect Showcase at The Sanctuary, Kiawah Island, SC. CEO Sulagna ...See details»
Nanoscope Therapeutics - Crunchbase Company …
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists.See details»
Nanoscope Therapeutics Continues Leadership Growth; Welcomes ...
Dec 4, 2023 New Addition Highlights Continued Enhancement of Organization's Strategic Trajectory. DALLAS, Dec. 4, 2023 /PRNewswire/ -- Nanoscope Therapeutics (Nanoscope), a …See details»
Nanotherapeutics, Inc. - Devex
Learn more about Nanotherapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Nanotherapeutics was founded in 1999 as an integrated …See details»
Overview, News & Similar companies - ZoomInfo.com
Who is Nanotherapeutics. Nanotherapeutics is an integrated biopharmaceutical company with a focus on development and manufacturing. The Company has expertise in preclinical and …See details»
Nanoscope Therapeutics Continues Leadership Growth; Welcomes ...
Dec 4, 2023 Nanoscope Therapeutics (Nanoscope), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced the appointment of …See details»
Nanoscope Therapeutics - VentureRadar
"Nanoscope Therapeutics is a clinical-stage biopharmaceutical company developing gene therapies to cure genetic diseases that cause vision impairment and blindness.See details»
Nanoscope Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Mar 8, 2025 www.nanostherapeutics.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. ... The …See details»
Nanoscope Therapeutics - PitchBook
Nanoscope Therapeutics General Information Description. Developer of a therapeutic gene and delivery platform designed to be used for vision restoration. The company is developing …See details»
Overview, News & Similar companies - ZoomInfo.com
Dec 4, 2023 View Nanoscope Therapeutics (www.nanostherapeutics.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well …See details»
Nanoscope Therapeutics: Employee Directory | ZoomInfo.com
Nanoscope Therapeutics Contact Info: Phone number: (817) 857-1186 Website: www.nanostherapeutics.com What does Nanoscope Therapeutics do? Nanoscope …See details»
Nanoscope Therapeutics Continues Leadership Growth; Welcomes ...
Dec 4, 2023 Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board New Addition …See details»
Nanoscope Therapeutics Inc. - Company Profile & Staff
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal …See details»
Nanoscope Therapeutics Announces 3 New Appointments to its …
DALLAS, April 4, 2022 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today …See details»
Nanoscope Therapeutics Announces 3 New Appointments to its …
DALLAS, April 4, 2022 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today …See details»
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as
7 hours ago Board of directors member, Cynthia Collins, will serve as executive chair; Dr. Khandros will remain on the board of Nutcracker Therapeutics; EMERYVILLE, Calif.- …See details»
Nanoscope Therapeutics CEO Sulagna Bhattacharya Elected to BIO …
DALLAS, Feb. 17, 2022 — Nanoscope Therapeutics Inc., a late clinical-stage ocular gene therapy company, today announced the election of CEO Sulagna Bhattacharya to the Biotechnology …See details»